Search

everythinglearnresearchcommunity

for

Search:↓

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Early diagnosis and treatment of achalasia and hyperthyroidism improve patient outcomes.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Alopecia areata involves immune response and gene changes affecting hair loss.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

A man with total hair loss also developed a rare nail condition, likely due to autoimmune issues.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

People with autism are more likely to develop alopecia areata than those without autism.

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.